Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.
about
Therapeutic Use of Metformin in Prediabetes and Diabetes PreventionThe prevention of type 2 diabetes.The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial InfarctLifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.Defining and achieving treatment success in patients with type 2 diabetes mellitusThe effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention ProgramLifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.Early response to preventive strategies in the Diabetes Prevention ProgramMetformin effects revisited.Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women.Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.Steps toward the meaningful translation of prevention strategies for type 2 diabetes.Insulin resistance in bipolar disorder: relevance to routine clinical care.Impact of weight changes on the incidence of diabetes mellitus: a Korean nationwide cohort study.
P2860
Q26822066-8A63C6D3-60ED-474A-9B7C-BBA08DE71C4DQ30484253-007D4E5C-C558-470C-89FD-53B476A3AA8FQ31033137-53A8B8B1-C3B4-47B6-BA3C-30D91967DD2AQ33960260-D8B04554-248B-406D-9009-BF7F96F180AAQ34294192-9D11CAD0-7AF5-4C86-B176-D0C29A1C53CFQ34374314-5B63F379-0089-4680-98B6-4976CAC5A30BQ34777753-04F3E885-5463-4CBE-80C1-2B0CDE247F45Q35841253-B60518EA-48C1-4F5A-BF80-8FD78C3469C4Q36359671-038AA9CE-072E-4AD1-9B38-9E898AC30ECEQ36862877-AD42D234-FE6F-4667-8163-2138ABEC51C9Q37215490-348B925C-9042-45C4-B8F2-9A4D06FC810AQ37321605-8DDDC77E-BA8A-41F9-BF67-C96B2C106BF7Q37554697-86D71C1F-55B3-475E-9335-F0DD0EDE3FF5Q37619545-D48E8A47-7276-4782-BDB2-6B4039B675C3Q37989177-CBD1F307-EDF8-49EE-8357-033F2C192F38Q38645269-F77057F5-93DD-4E62-BCCE-B688FCE0E8B8Q38753212-E5F5F68D-2A48-43D1-A57C-E788EF9238D7Q42575788-87A41752-9689-4825-98C8-B509E08BEBF6Q50571436-5BE35FF8-FE40-42D9-9906-CA8A967DA5D3Q51246364-D7AC277F-7777-4FF2-962E-CC3939E46D2B
P2860
Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factors associated with diabet ...... e diabetes prevention program.
@en
type
label
Factors associated with diabet ...... e diabetes prevention program.
@en
prefLabel
Factors associated with diabet ...... e diabetes prevention program.
@en
P2093
P2860
P50
P356
P1433
P1476
Factors associated with diabet ...... e diabetes prevention program.
@en
P2093
Costas A Christophi
DDK Research Group
David A Ehrmann
David M Nathan
Richard F Hamman
Sharon L Edelstein
P2860
P304
P356
10.2337/DB06-0918
P407
P577
2007-04-01T00:00:00Z